Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avecho Biotechnology Ord Shs V.AVE


Primary Symbol: AVEFF

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.


OTCPK:AVEFF - Post by User

Comment by zadmanon Apr 17, 2018 12:49am
260 Views
Post# 27895354

RE:RE:RE:Terms

RE:RE:RE:TermsGetting long Aveda here also gives you free leverage to deseke stock in the US which if you look at its chart, was MATERIALLY higher a couple months ago.  If that stock rallies our 90 cent floor rises thanks to the exchange ratio.  If it tanks, you elect for the 90 cent CAD cash.  I think Aveda is a good buy to about a dollar and then above that - only if you believe in the companies ability to generate EBITDA over 18MM (which for the record I do).  


One thing of note some may not be aware of - go to deseke investor page on their website.  There’s a link to the conference call held this morning to discuss the acquisition.  No aveda personel, only deseke.  Did learn that for any 3rd party trucking expenses that Aveda was subbing out (long haul rig moves etc), they will get a 7% of gross rev credit towards their EBITDA earn out calculation.  Don’t know how material this will be but I view it as another positive.  That, them hiring crane operators and the rig count and oil price trend = YUGE opportunity for margin expansion.

zad
<< Previous
Bullboard Posts
Next >>